ZENTALIS PHARMACEUTICALS INC (ZNTL)
US98943L1070 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to ZNTL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.09. This target is 219.56% above the current price.
ZNTL was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ZNTL.
In the previous month the buy percentage consensus was at a similar level.
ZNTL was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-28 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-08 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-11-07 | Stifel | Maintains | Buy -> Buy |
| 2023-11-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-07 | Stifel | Maintains | Buy -> Buy |
| 2023-06-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-26 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-26 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-19 | Jefferies | Maintains | Buy -> Buy |
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-14 | Wedbush | Maintains | Outperform |
| 2022-11-11 | Guggenheim | Maintains | Buy |
| 2022-11-11 | Morgan Stanley | Maintains | Overweight |
| 2022-11-10 | Oppenheimer | Maintains | Outperform |
| 2022-11-10 | SVB Leerink | Maintains | Outperform |
| 2022-08-11 | Morgan Stanley | Maintains | Overweight |
| 2022-08-10 | SVB Leerink | Maintains | Outperform |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-12 | Cowen & Co. | Initiate | Outperform |
| 2022-04-12 | Oppenheimer | Maintains | Outperform |
| 2022-04-12 | SVB Leerink | Maintains | Outperform |
| 2021-12-17 | SVB Leerink | Maintains | Outperform |